FMP
Theratechnologies Inc.
TH.TO
TSX
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH1902, which is in Phase 1/Part A clinical trials for the treatment of triple negative breast cancer; and TH1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
1.8 CAD
-0.05 (-2.78%)
About
ceo
Mr. Paul Lévesque
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.theratech.com
exchange
TSX
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH1902, which is in Phase 1/Part A clinical trials for the treatment of triple negative breast cancer; and TH1904 for ...
CIK
N/A
ISIN
CA88338H7040
CUSIP
N/A
Address
2015 Peel Street
Phone
15143367800
Country
CA
Employee
103
IPO Date
Aug 6, 1996
Summary
CIK
-
Exchange
TSX
Industry
Drug Manufacturers -...
Sector
Healthcare
CUSIP
-
ISIN
CA88338H7040
Country
CA
Price
1.8
Beta
1.78
Volume Avg.
27.87k
Market Cap
82.76M
Shares
-
52-Week
1.22-5.84
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.44
P/B
-
Website
https://www.theratech.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest TH.TO News
It looks like there's no news available.
